The effect of almond intake on glycemic control: A systematic review and dose-response meta-analysis of randomized controlled trials

Phytother Res. 2022 Jan;36(1):395-414. doi: 10.1002/ptr.7328. Epub 2021 Nov 29.

Abstract

Number trials have evaluated the effect of almond intake on glycemic control in adults; however, the results remain equivocal. Therefore, the present meta-analysis aims to examine the effectiveness of almond intake on glycemic parameters. Online databases including PubMed, Scopus, ISI web of science, Embase, and Cochrane Library were searched up to August 2021 for trials that examined the effect of almond intake on glycemic control parameters including fasting blood sugar (FBS), insulin, HOMA-IR, and HbA1C. Treatment effects were expressed as mean difference (MD) and the standard deviation (SD) of outcomes. To estimate the overall effect of almond intake, we used the random-effects model. In total, 24 studies with 31 arms were included in our analysis. The meta-analysis revealed that almond intake did not significantly change the concentrations of FBS, HbA1c, insulin levels, and HOMA-IR. In conclusion, there is currently no convincing evidence that almonds have a clear beneficial effect on glycemic control. Future studies are needed before any confirmed conclusion could be drowned.

Keywords: almond; glycemic control; meta-analysis; nuts; systematic review.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Blood Glucose
  • Humans
  • Insulin
  • Insulin Resistance*
  • Prunus dulcis*
  • Randomized Controlled Trials as Topic

Substances

  • Blood Glucose
  • Insulin